The recent arrival here of the 40mg Tirzepatide dose represents a potentially revolutionary advancement in the approach of type 2 diabetes . This drug builds upon the prior success of lower amounts, showing encouraging results in lowering blood glycemic control and promoting weight loss . Experts are investigating its full effect on heart outcomes